Virtual Library

Start Your Search

G. Visockyte



Author of

  • +

    P1.03 - Poster Session with Presenters Present (ID 455)

    • Event: WCLC 2016
    • Type: Poster Presenters Present
    • Track: Radiology/Staging/Screening
    • Presentations: 1
    • +

      P1.03-082 - 18F-FDG PET/CT Value Staging NSCLC Extension to the Lymph Nodes, Single Center Experience (ID 6118)

      14:30 - 14:30  |  Author(s): G. Visockyte

      • Abstract
      • Slides

      Background:
      Non small-cell lung carcinoma (NSCLC) is the most common type of lung cancer. Correct clinical and pathological lymphnode (N) staging is critical for choosing the best treatment. Positron emission tomography/computed tomography (PET/CT), being non-invasive pre-operative diagnostic method is becoming increasingly popular. Therefore, we aimed to evaluate the accuracy same as false-negative and false-positive results of PET/CT when compared to histopathological diagnoses at Vilnius university hospital Santariskiu klinikos (VUL SK).

      Methods:
      A retrospective analysis included 15 NSCLC patients who underwent preoperative PET/CT scan and postoperative histopathological analysis for the N staging at VUL SK. PET/CT N stage was compared with gold standard histopathological N stage to assess the sensitivity, specificity, positive and negative predictive values for N staging of NSCLC.

      Results:
      There were 15 patients (11 men (73,3%), 4 women (26,7%)) with average age of 66,1±10,2 years included into the study. Ten patients (66,7%) were staged N>0 by PET/CT, histopathological analysis confirmed 4 diagnoses (40%), other 6 diagnoses (60%) were considered false positive. Five patients (33,3%) were staged N0 by PET/CT, histopathological analysis confirmed 3 diagnoses (60%), other 2 diagnoses (40%) were false negative. Estimated specificity of PET/CT for N staging of NSCLC was 25%; sensitivity – 57,14%, positive predictive value – 40%, negative predictive value – 60%.

      Conclusion:
      Despite many advantages, PET/CT still has limited value staging NSCLC. Significant number of inaccuracies in N staging may occur evaluating inflammatory lymph nodes. The necessity of histologic confirmation of N stage in stage I-IIIa NSCLC is crucial as these patients may have surgical treatment combination and better outcomes.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.